| 臺大學術典藏 |
2022-02-21T03:52:32Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:31Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:30Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC
|
Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-18T08:46:46Z |
A training program of a new simplified classification of magnified narrow band imaging for superficial esophageal squamous cell carcinoma
|
Wang W.-L.; Chiu S.Y.-H.; Lee C.-T.; Tseng C.-H.; CHIEN-CHUAN CHEN; Han M.-L.; Chung C.-S.; Hsieh P.-H.; Chang W.-L.; Wu P.-H.; Hsu W.-H.; Yen H.-H.; Wang H.-P.; Chang C.-Y. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 國立成功大學 |
2022 |
Machine learning approaches for screening the risk of obstructive sleep apnea in the Taiwan population based on body profile
|
Tsai, C.-Y.;Liu, W.-T.;Lin, Y.-T.;Lin, S.-Y.;Houghton, R.;Hsu, W.-H.;Wu, D.;Lee, H.-C.;Wu, C.-J.;Li, Li L.Y.J.;Hsu, S.-M.;Lo, C.-C.;Lo, K.;Chen, Y.-R.;Lin, F.-C.;Majumdar, A. |
| 國立成功大學 |
2022 |
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
|
Wang, M.;Yang, J.C.-H.;Mitchell, P.L.;Fang, J.;Camidge, D.R.;Nian, W.;Chiu, Chiu C.-H.;Zhou, J.;Zhao, Y.;Su, W.-C.;Yang, T.-Y.;Zhu, V.W.;Millward, Millward M.;Fan, Y.;Huang, W.-T.;Cheng, Y.;Jiang, L.;Brungs, D.;Bazhenova, L.;Lee, C.K.;Gao, B.;Xu, Y.;Hsu, W.-H.;Zheng, L.;J�nne, P.A. |
| 國立成功大學 |
2022 |
GMI, Ganoderma microsporum protein, suppresses cell mobility and increases temozolomide sensitivity through induction of Slug degradation in glioblastoma multiforme cells
|
Tseng, A.-J.;Tu, Tu T.-H.;Hua, W.-J.;Yeh, H.;Chen, Chen C.-J.;Lin, Z.-H.;Hsu, W.-H.;Chen, Y.-L.;Hsu, C.-C.;Lin, T.-Y. |
| 國立成功大學 |
2022 |
Probiotics-Derived Extracellular Vesicles Protect Oxidative Stress against H2 O2 Induction in Placental Cells
|
Wang, L.-M.;Lee, B.-H.;Hou, C.-Y.;Hsu, W.-H.;Tai, C.-J. |
| 臺大學術典藏 |
2021-11-22T02:27:22Z |
The C-Terminal Sequence and PI motif of the Orchid (Oncidium Gower Ramsey) PISTILLATA (PI) Ortholog Determine its Ability to Bind AP3 Orthologs and Enter the Nucleus to Regulate Downstream Genes Controlling Petal and Stamen Formation
|
Mao, W.-T.; Hsu, H.-F.; Hsu, W.-H.; Li, J.-Y.; Lee, Y.-I.; Yang, C.-H. |
| 臺大學術典藏 |
2021-11-03T05:24:55Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-11-03T02:33:02Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; JIN-YUAN SHIH; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-09-23T08:21:26Z |
Significant Elevation in Potassium Concentration Surrounding Stimulated Excitable Cells Revealed by an Aptamer-Modified Nanowire Transistor
|
Anand, A.; Tseng, H.-C.; Chiang, H.-C.; Hsu, W.-H.; Liao, Y.-F.; Lu, S.H.-A.; Tsai, S.-Y.; Pan, C.-Y.; Chen, Y.-T.; YIT-TSONG CHEN |
| 臺大學術典藏 |
2021-09-02T00:08:59Z |
Learn from the past – sequentially one-to-one video deblurring network
|
Liang C.-H;Su H.-T;Hsu W.H.; Liang C.-H; Su H.-T; Hsu W.H.; WINSTON HSU |
| 臺大學術典藏 |
2021-09-02T00:08:59Z |
Indoor depth completion with boundary consistency and self-attention
|
Huang Y.-K;Wu T.-H;Liu Y.-C;Hsu W.H.; Huang Y.-K; Wu T.-H; Liu Y.-C; Hsu W.H.; WINSTON HSU |
| 臺大學術典藏 |
2021-09-02T00:08:59Z |
End-to-End Video Question-Answer Generation with Generator-Pretester Network
|
Su H;Chang C;Shen P;Wang Y;Chang Y;Chang Y;Cheng P;Hsu W.H.; Su H; Chang C; Shen P; Wang Y; Chang Y; Chang Y; Cheng P; Hsu W.H.; WINSTON HSU |
| 臺大學術典藏 |
2021-09-02T00:08:58Z |
Situation and behavior understanding by trope detection on films
|
Chang C.-H;Su H.-T;Hsu J.-H;Wang Y.-S;Chang Y.-C;Liu Z.Y;Chang Y.-L;Cheng W.-F;Wang K.-J;Hsu W.H.; Chang C.-H; Su H.-T; Hsu J.-H; Wang Y.-S; Chang Y.-C; Liu Z.Y; Chang Y.-L; Cheng W.-F; Wang K.-J; Hsu W.H.; WINSTON HSU |
| 臺大學術典藏 |
2021-09-02T00:08:47Z |
End-to-End Video Question-Answer Generation with Generator-Pretester Network
|
Su H;Chang C;Shen P;Wang Y;Chang Y;Chang Y;Cheng P;Hsu W.H.; Su H; Chang C; Shen P; Wang Y; Chang Y; Chang Y; Cheng P; Hsu W.H.; PU-JEN CHENG |
| 臺大學術典藏 |
2021-09-02T00:04:50Z |
Photoacoustic signal enhancements from gold nano-colloidal suspensions excited by a pair of time-delayed femtosecond pulses
|
Masim F.C.P;Hsu W.-H;Liu H.-L;Yonezawa T;Bal?ytis A;Juodkazis S;Hatanaka K.; Masim F.C.P; Hsu W.-H; Liu H.-L; Yonezawa T; Bal?ytis A; Juodkazis S; Hatanaka K.; HAO-LI LIU |
| 臺大學術典藏 |
2021-08-31T06:29:39Z |
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
|
Liang Y.-H.; Wei C.-H.; Hsu W.-H.; Shao Y.-Y.; Lin Y.-C.; Chou P.-C.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-31T03:33:45Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
SHU-YUNG LIN; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:40Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; BIN-CHI LIAO; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:39Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; BIN-CHI LIAO; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:38Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; BIN-CHI LIAO; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:38Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC
|
BIN-CHI LIAO; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:37Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
LEE JIH-HSIANG; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:33Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-13T06:04:30Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-13T06:04:27Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-05T05:42:02Z |
Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells
|
Chang C.-C.; Hsu W.-H.; Wang C.-C.; Chou C.-H.; YEN-PING KUO; Lin B.-R.; Chen S.-T.; Tai S.-K.; Kuo M.-L.; Yang M.-H. |
| 臺大學術典藏 |
2021-07-05T03:41:22Z |
Synthesis of metal ion-histidine complex functionalized mesoporous silica nanocatalysts for enhanced light-free tooth bleaching
|
BOR-SHIUNN LEE; Huang L.-C.; Hong C.-Y.; Wang S.-G.; Hsu W.-H.; Yamauchi Y.; Hsieh C.-J.; Lai J.-Y.; Wu K.C.-W. |
| 臺大學術典藏 |
2021-06-22T02:00:52Z |
The applications of Lactobacillus plantarum-derived extracellular vesicles as a novel natural antibacterial agent for improving quality and safety in tuna fish
|
Lee, B.-H.;Wu, S.-C.;Shen, T.-L.;Hsu, Y.-Y.;Chen, C.-H.;Hsu, W.-H.; Lee, B.-H.; Wu, S.-C.; Shen, T.-L.; Hsu, Y.-Y.; Chen, C.-H.; Hsu, W.-H.; TANG-LONG SHEN |
| 臺大學術典藏 |
2021-06-15T03:12:02Z |
Management of Crohn's disease in Taiwan: Consensus guideline of the Taiwan society of inflammatory bowel disease
|
SHU-CHEN WEI; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Lin W.-C.; Ni Y.-H.; Shieh M.-J.; Shih I.-L.; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-06-15T03:12:02Z |
Elderly Adults with Late-Onset Ulcerative Colitis Tend to Have Atypical, Milder Initial Clinical Presentations but Higher Surgical Rates and Mortality: A Taiwan Society of Inflammatory Bowel Disease Study
|
Lin W.-C.; Tung C.-C.; Lin H.-H.; Lin C.-C.; Chang C.-W.; Yen H.-H.; Chuang C.-H.; Hsu W.-H.; Tsai W.-S.; Wang H.-Y.; Lin J.-K.; SHU-CHEN WEI; Wong J.-M. |
| 臺大學術典藏 |
2021-06-15T03:12:01Z |
Management of ulcerative colitis in Taiwan: Consensus guideline of the Taiwan Society of inflammatory bowel disease
|
SHU-CHEN WEI; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Lin W.-C.; Ni Y.-H.; Shieh M.-J.; Shih I.-L.; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-06-15T03:12:01Z |
Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study
|
Lin W.-C.; Chou J.-W.; Yen H.-H.; Hsu W.-H.; Lin H.-H.; Lin J.-K.; Chuang C.-H.; Huang T.-Y.; Wang H.-Y.; SHU-CHEN WEI; Wong J.-M. |
| 臺大學術典藏 |
2021-06-04T06:23:09Z |
Combined proteomic and metabolomic analyses of cerebrospinal fluid from mice with ischemic stroke reveals the effects of a Buyang Huanwu decoction in neurodegenerative disease
|
Hsu W.-H.;Shen Y.-C.;Shiao Y.-J.;Ching-Hua Kuo;Lu C.-K.;Lin T.-Y.;Ku W.-C.;Lin Y.-L.; Hsu W.-H.; Shen Y.-C.; Shiao Y.-J.; CHING-HUA KUO; Lu C.-K.; Lin T.-Y.; Ku W.-C.; Lin Y.-L. |
| 臺大學術典藏 |
2021-06-04T06:23:04Z |
ASIC3-dependent metabolomics profiling of serum and urine in a mouse model of fibromyalgia
|
Hsu W.-H.;Lee C.-H.;Chao Y.-M.;Ching-Hua Kuo;Ku W.-C.;Chen C.-C.;Lin Y.-L.; Hsu W.-H.; Lee C.-H.; Chao Y.-M.; CHING-HUA KUO; Ku W.-C.; Chen C.-C.; Lin Y.-L. |
| 臺大學術典藏 |
2021-05-18T05:57:09Z |
Design of a sinuous route monopole antenna for handset
|
Hsu W.-H.; YU-TSUNG HUANG; Pan S.-C. |
| 臺大學術典藏 |
2021-05-18T05:57:02Z |
A well placement design to improve GSM/DCS and GPS antenna isolation
|
Hsu W.-H.; Pan S.-C.; YU-TSUNG HUANG |
| 臺大學術典藏 |
2021-05-18T05:56:41Z |
High isolation 2.4/5.2/5.8 GHz WLAN and 2.5 GHz WiMAX antennas for laptop computer application
|
YU-TSUNG HUANG; Li C.-T.; Chang W.-S.; Hsu W.-H. |
| 臺大學術典藏 |
2021-05-14T05:40:07Z |
A training program of a new simplified classification of magnified narrow band imaging for superficial esophageal squamous cell carcinoma
|
Wang W.-L.; Chiu S.Y.-H.; Lee C.-T.; Tseng C.-H.; Chen C.-C.; MING-LUN HAN; Chung C.-S.; Hsieh P.-H.; Chang W.-L.; Wu P.-H.; Hsu W.-H.; Yen H.-H.; Wang H.-P.; Chang C.-Y. |
| 臺大學術典藏 |
2021-05-07T02:46:34Z |
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
|
YI-HSIN LIANG; Wei C.-H.; Hsu W.-H.; Shao Y.-Y.; Lin Y.-C.; Chou P.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-05-02T04:47:35Z |
Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes
|
Chen Y.-C.; Tsai Y.-H.; Wang C.-C.; Liu S.-F.; Chen T.-W.; Fang W.-F.; Lee C.-P.; Hsu P.-Y.; Chao T.-Y.; Wu C.-C.; Wei Y.-F.; Chang H.-C.; Tsen C.-C.; Chang Y.-P.; Lin M.-C.; Yu C.-J.; HAO-CHIEN WANG; Chiang C.-H.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Hsiue T.-R.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Chong I.-W.; Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group |
| 臺大學術典藏 |
2021-05-02T03:29:19Z |
Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes
|
Chen Y.-C.; Tsai Y.-H.; Wang C.-C.; Liu S.-F.; Chen T.-W.; Fang W.-F.; Lee C.-P.; Hsu P.-Y.; Chao T.-Y.; Wu C.-C.; Wei Y.-F.; Chang H.-C.; Tsen C.-C.; Chang Y.-P.; Lin M.-C.; CHONG-JEN YU; Wang H.-C.; Chiang C.-H.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Hsiue T.-R.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Chong I.-W.; Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group |
| 臺大學術典藏 |
2021-04-29T05:09:06Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
Lee J.-H.; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; KUAN-YU CHEN; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-04-29T05:08:54Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T05:08:50Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Kuan-Yu Chen;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T05:08:48Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Kuan-Yu Chen;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-23T05:56:28Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Chih-Hsin Yang;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; CHIH-HSIN YANG; Yu C.-J. |
